Skip to main content

Research Repository

Advanced Search

Metallotexaphyrins as MRI-Active Catalytic Antioxidants for Neurodegenerative Disease: A Study on Alzheimer’s Disease

Brewster II, James T.; Thiabaud, Gregory D.; Harvey, Peter; Zafar, Hadiqa; Reuther, James F.; Dell'Acqua, Simone; Johnson, Rachel M.; Root, Harrison D.; Metola, Pedro; Jasanoff, Alan; Casella, Luigi; Sessler, Jonathan L.

Metallotexaphyrins as MRI-Active Catalytic Antioxidants for Neurodegenerative Disease: A Study on Alzheimer’s Disease Thumbnail


Authors

James T. Brewster II

Gregory D. Thiabaud

Hadiqa Zafar

James F. Reuther

Simone Dell'Acqua

Rachel M. Johnson

Harrison D. Root

Pedro Metola

Alan Jasanoff

Luigi Casella

Jonathan L. Sessler



Abstract

The complex etiology of neurodegeneration continues to stifle efforts to develop effective therapeutics. New agents elucidating key pathways causing neurodegeneration might serve to increase our understanding and potentially lead to improved treatments. Here, we demonstrate that a water soluble manganese(II) texaphyrin (MMn) is a suitable magnetic resonance imaging (MRI) contrast agent for detecting larger amyloid beta constructs. The imaging potential of MMn was inferred on the basis of in vitro studies and in vivo detection in Alzheimer's disease C. elegans models using MRI and ICP-MS. In vitro antioxidant and cellular-based assays provide support for the notion that this porphyrin analogue shows promise as a therapeutic agent able to mitigate the oxidative and nitrative toxic effects considered causal in neurodegeneration. The present report marks the first elaboration of an MRI-active metalloantioxidant that confers diagnostic and therapeutic benefit in Alzheimer's disease models without conjugation of a radioisotope, targeting moiety, or therapeutic payload.

Citation

Brewster II, J. T., Thiabaud, G. D., Harvey, P., Zafar, H., Reuther, J. F., Dell'Acqua, S., …Sessler, J. L. (2020). Metallotexaphyrins as MRI-Active Catalytic Antioxidants for Neurodegenerative Disease: A Study on Alzheimer’s Disease. Chem, 6(3), 703-724. https://doi.org/10.1016/j.chempr.2019.12.016

Journal Article Type Article
Acceptance Date Dec 13, 2019
Online Publication Date Jan 9, 2020
Publication Date Mar 12, 2020
Deposit Date Dec 19, 2019
Publicly Available Date Dec 19, 2019
Journal Chem
Electronic ISSN 2451-9294
Publisher Elsevier
Peer Reviewed Peer Reviewed
Volume 6
Issue 3
Pages 703-724
DOI https://doi.org/10.1016/j.chempr.2019.12.016
Keywords Materials Chemistry; Biochemistry; General Chemistry; General Chemical Engineering; Biochemistry, medical; Environmental Chemistry
Public URL https://nottingham-repository.worktribe.com/output/3600895
Publisher URL https://www.sciencedirect.com/science/article/pii/S2451929419305637?via%3Dihub

Files





You might also like



Downloadable Citations